These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 17549378

  • 21. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma.
    Yarbrough WG.
    Laryngoscope; 2002 Dec; 112(12):2114-28. PubMed ID: 12461329
    [Abstract] [Full Text] [Related]

  • 22. Detailed gene expression analysis but not microsatellite marker analysis of 9p21 reveals differential defects in the INK4a gene locus in the majority of head and neck cancers.
    Grüttgen A, Reichenzeller M, Jünger M, Schlien S, Affolter A, Bosch FX.
    J Pathol; 2001 Jul; 194(3):311-7. PubMed ID: 11439363
    [Abstract] [Full Text] [Related]

  • 23. Ovarian cancer cells that coexpress endogenous Rb and p16 are insensitive to overexpression of functional p16 protein.
    Todd MC, Sclafani RA, Langan TA.
    Oncogene; 2000 Jan 13; 19(2):258-64. PubMed ID: 10645004
    [Abstract] [Full Text] [Related]

  • 24. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck.
    Zhang SY, Klein-Szanto AJ, Sauter ER, Shafarenko M, Mitsunaga S, Nobori T, Carson DA, Ridge JA, Goodrow TL.
    Cancer Res; 1994 Oct 01; 54(19):5050-3. PubMed ID: 7923115
    [Abstract] [Full Text] [Related]

  • 25. Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma.
    Nakamura T, Ide H, Eguchi R, Hayashi K, Takasaki K.
    Hepatogastroenterology; 2003 Oct 01; 50(53):1321-6. PubMed ID: 14571727
    [Abstract] [Full Text] [Related]

  • 26. Deletion of P15 (MTS2) in head and neck squamous cell carcinomas.
    Roesler JM, Livingston EH, Srivatsan E, Chang P, Wang MB.
    J Surg Res; 1998 Jun 01; 77(1):50-4. PubMed ID: 9698532
    [Abstract] [Full Text] [Related]

  • 27. Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer.
    Chatterjee SJ, George B, Goebell PJ, Alavi-Tafreshi M, Shi SR, Fung YK, Jones PA, Cordon-Cardo C, Datar RH, Cote RJ.
    J Pathol; 2004 Jul 01; 203(3):762-70. PubMed ID: 15221935
    [Abstract] [Full Text] [Related]

  • 28. CDKN2A/p16 is inactivated in most melanoma cell lines.
    Castellano M, Pollock PM, Walters MK, Sparrow LE, Down LM, Gabrielli BG, Parsons PG, Hayward NK.
    Cancer Res; 1997 Nov 01; 57(21):4868-75. PubMed ID: 9354451
    [Abstract] [Full Text] [Related]

  • 29. Modes of silencing of p16 in development of esophageal squamous cell carcinoma.
    Tokugawa T, Sugihara H, Tani T, Hattori T.
    Cancer Res; 2002 Sep 01; 62(17):4938-44. PubMed ID: 12208744
    [Abstract] [Full Text] [Related]

  • 30. The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung.
    Beasley MB, Lantuejoul S, Abbondanzo S, Chu WS, Hasleton PS, Travis WD, Brambilla E.
    Hum Pathol; 2003 Feb 01; 34(2):136-42. PubMed ID: 12612881
    [Abstract] [Full Text] [Related]

  • 31. [The expression of P16, Rb and cyclin D1 and biological behavior of laryngeal cancer].
    Dai S, Huang W, Gan X.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Oct 01; 32(5):299-301. PubMed ID: 10743098
    [Abstract] [Full Text] [Related]

  • 32. Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions.
    Brambilla E, Gazzeri S, Moro D, Lantuejoul S, Veyrenc S, Brambilla C.
    Clin Cancer Res; 1999 Feb 01; 5(2):243-50. PubMed ID: 10037171
    [Abstract] [Full Text] [Related]

  • 33. Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.
    Krämer A, Schultheis B, Bergmann J, Willer A, Hegenbart U, Ho AD, Goldschmidt H, Hehlmann R.
    Leukemia; 2002 Sep 01; 16(9):1844-51. PubMed ID: 12200702
    [Abstract] [Full Text] [Related]

  • 34. HPV infection and the alterations of the pRB pathway in oral carcinogenesis.
    Lim KP, Hamid S, Lau SH, Teo SH, Cheong SC.
    Oncol Rep; 2007 Jun 01; 17(6):1321-6. PubMed ID: 17487385
    [Abstract] [Full Text] [Related]

  • 35. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma.
    Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Bartek J, Sidransky D.
    Cancer Res; 1996 Aug 15; 56(16):3630-3. PubMed ID: 8705996
    [Abstract] [Full Text] [Related]

  • 36. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.
    Burnworth B, Arendt S, Muffler S, Steinkraus V, Bröcker EB, Birek C, Hartschuh W, Jauch A, Boukamp P.
    Eur J Cell Biol; 2007 Dec 15; 86(11-12):763-80. PubMed ID: 17198740
    [Abstract] [Full Text] [Related]

  • 37. Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer.
    Benedict WF, Lerner SP, Zhou J, Shen X, Tokunaga H, Czerniak B.
    Oncogene; 1999 Feb 04; 18(5):1197-203. PubMed ID: 10022125
    [Abstract] [Full Text] [Related]

  • 38. No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours.
    Jefferies S, Edwards SM, Hamoudi RA, A'Hern R, Foulkes W, Goldgar D, Eeles R, MPT Collaborators.
    Br J Cancer; 2001 Nov 02; 85(9):1383-6. PubMed ID: 11720478
    [Abstract] [Full Text] [Related]

  • 39. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck.
    Begum S, Gillison ML, Nicol TL, Westra WH.
    Clin Cancer Res; 2007 Feb 15; 13(4):1186-91. PubMed ID: 17317828
    [Abstract] [Full Text] [Related]

  • 40. Familial head and neck cancer: molecular analysis of a new clinical entity.
    Yu KK, Zanation AM, Moss JR, Yarbrough WG.
    Laryngoscope; 2002 Sep 15; 112(9):1587-93. PubMed ID: 12352668
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.